NSE has issued RFPs to investment banks for its upcoming IPO, targeting an adviser selection by April. The move follows Sebi’s 30 January no-objection clearance.
2 min read26 Feb 2026General Atlantic, KKR and CVC are among global PE firms evaluating a minority stake in IndiaRF-backed Synthimed, which is seeking a $1 billion valuation ahead of a planned IPO.
4 min read24 Feb 2026Novartis India shares rose 18% after Novartis AG agreed to sell its 70.68% stake to a consortium, triggering a mandatory open offer. The open offer allows public shareholders to tender 26% of equity at ₹860.64 per share, marking a significant control shift.
3 min read20 Feb 2026The OFS for BHEL is set at a floor price of ₹254, with the government offloading a 3% stake. Analysts recommend a gradual accumulation approach, emphasizing that the stock is more suited for patient investors.
3 min read12 Feb 2026The government aims to sell 3% in BHEL, with a green shoe option to divest an additional 2%. The sale is part of the government's divestment plan for FY26.
1 min read10 Feb 2026The valuation discovery is still underway as the company aims to professionalize ahead of a public listing. Established in 1994, it specializes in contract manufacturing for personal care and cosmetics.
2 min read5 Feb 2026Vedanta announced its Committee of Directors approved the sale of up to 6.7 crore equity shares of Hindustan Zinc, representing a 1.59% stake, via an offer-for-sale route, adhering to regulations set by the Securities and Exchange Board of India.
1 min read27 Jan 2026The bank planned to cut stake in Axis Finance. But the central bank last month withdrew its draft circular, allowing banks to continue with overlapping non-bank lending operations through their subsidiaries.
2 min read26 Jan 2026Kedaara Capital is set to acquire a majority stake in Tynor Orthotics at a ₹3,500–4,000 crore valuation, enabling Lighthouse Funds’ exit and funding the company’s next phase of expansion.
2 min read7 Jan 2026Samsung Life, Prudential Plc, BNP Paribas and Norwest Venture Partners are evaluating the purchase of Warburg Pincus’s stake, in what insiders describe as a pre-IPO transaction that could value the insurer at over ₹10,000 crore.
3 min read29 Dec 2025